{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,5]],"date-time":"2026-07-05T03:49:34Z","timestamp":1783223374656,"version":"3.54.6"},"reference-count":30,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2016,3,7]],"date-time":"2016-03-07T00:00:00Z","timestamp":1457308800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/501100001700","name":"Ministry of Education, Culture, Sports, Science, and Technology (JP)","doi-asserted-by":"publisher","award":["20590694"],"award-info":[{"award-number":["20590694"]}],"id":[{"id":"10.13039\/501100001700","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001700","name":"Ministry of Education, Culture, Sports, Science, and Technology (JP)","doi-asserted-by":"publisher","award":["20300184"],"award-info":[{"award-number":["20300184"]}],"id":[{"id":"10.13039\/501100001700","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Clin Exp Nephrol"],"published-print":{"date-parts":[[2016,12]]},"DOI":"10.1007\/s10157-016-1253-0","type":"journal-article","created":{"date-parts":[[2016,3,6]],"date-time":"2016-03-06T21:55:44Z","timestamp":1457301344000},"page":"862-870","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":11,"title":["Effect of clofibrate on fatty acid metabolism in the kidney of puromycin-induced nephrotic rats"],"prefix":"10.1007","volume":"20","author":[{"given":"Yoshikazu","family":"Muroya","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Osamu","family":"Ito","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2016,3,7]]},"reference":[{"issue":"9","key":"1253_CR1","doi-asserted-by":"publisher","first-page":"1560","DOI":"10.1038\/sj.ki.5001834","volume":"70","author":"JM Weinberg","year":"2006","unstructured":"Weinberg JM. Lipotoxicity. Kidney Int. 2006;70(9):1560\u20136. doi: 10.1038\/sj.ki.5001834 .","journal-title":"Kidney Int"},{"issue":"10","key":"1253_CR2","doi-asserted-by":"crossref","first-page":"5678","DOI":"10.1074\/jbc.273.10.5678","volume":"273","author":"T Aoyama","year":"1998","unstructured":"Aoyama T, Peters JM, Iritani N, Nakajima T, Furihata K, Hashimoto T, et al. Altered constitutive expression of fatty acid-metabolizing enzymes in mice lacking the peroxisome proliferator-activated receptor \u03b1 (PPAR\u03b1). J Biol Chem. 1998;273(10):5678\u201384.","journal-title":"J Biol Chem"},{"issue":"4","key":"1253_CR3","doi-asserted-by":"publisher","first-page":"1208","DOI":"10.1111\/j.1523-1755.2002.kid553.x","volume":"62","author":"D Portilla","year":"2002","unstructured":"Portilla D, Dai G, McClure T, Bates L, Kurten R, Megyesi J, et al. Alterations of PPAR\u03b1 and its coactivator PGC-1 in cisplatin-induced acute renal failure. Kidney Int. 2002;62(4):1208\u201318. doi: 10.1111\/j.1523-1755.2002.kid553.x .","journal-title":"Kidney Int"},{"issue":"11","key":"1253_CR4","doi-asserted-by":"publisher","first-page":"9013","DOI":"10.1074\/jbc.M212923200","volume":"278","author":"SN Schreiber","year":"2003","unstructured":"Schreiber SN, Knutti D, Brogli K, Uhlmann T, Kralli A. The transcriptional coactivator PGC-1 regulates the expression and activity of the orphan nuclear receptor estrogen-related receptor \u03b1 (ERR\u03b1). J Biol Chem. 2003;278(11):9013\u20138. doi: 10.1074\/jbc.M212923200 .","journal-title":"J Biol Chem"},{"issue":"9","key":"1253_CR5","doi-asserted-by":"crossref","first-page":"5400","DOI":"10.1128\/MCB.17.9.5400","volume":"17","author":"R Sladek","year":"1997","unstructured":"Sladek R, Bader JA, Giguere V. The orphan nuclear receptor estrogen-related receptor alpha is a transcriptional regulator of the human medium-chain acyl coenzyme A dehydrogenase gene. Mol Cell Biol. 1997;17(9):5400\u20139.","journal-title":"Mol Cell Biol"},{"issue":"1","key":"1253_CR6","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1016\/j.bbagen.2009.10.009","volume":"1800","author":"KH Cho","year":"2010","unstructured":"Cho KH, Kim HJ, Kamanna VS, Vaziri ND. Niacin improves renal lipid metabolism and slows progression in chronic kidney disease. Biochim Biophys Acta. 2010;1800(1):6\u201315. doi: 10.1016\/j.bbagen.2009.10.009 .","journal-title":"Biochim Biophys Acta"},{"issue":"6","key":"1253_CR7","doi-asserted-by":"publisher","first-page":"F1297","DOI":"10.1152\/ajprenal.90761.2008","volume":"296","author":"HJ Kim","year":"2009","unstructured":"Kim HJ, Moradi H, Yuan J, Norris K, Vaziri ND. Renal mass reduction results in accumulation of lipids and dysregulation of lipid regulatory proteins in the remnant kidney. Am J Physiol Renal Physiol. 2009;296(6):F1297\u2013306. doi: 10.1152\/ajprenal.90761.2008 .","journal-title":"Am J Physiol Renal Physiol"},{"issue":"10","key":"1253_CR8","doi-asserted-by":"publisher","first-page":"1049","DOI":"10.1038\/ki.2009.330","volume":"76","author":"S Li","year":"2009","unstructured":"Li S, Nagothu KK, Desai V, Lee T, Branham W, Moland C, et al. Transgenic expression of proximal tubule peroxisome proliferator-activated receptor-\u03b1 in mice confers protection during acute kidney injury. Kidney Int. 2009;76(10):1049\u201362. doi: 10.1038\/ki.2009.330 .","journal-title":"Kidney Int"},{"issue":"4","key":"1253_CR9","doi-asserted-by":"crossref","first-page":"F667","DOI":"10.1152\/ajprenal.2000.278.4.F667","volume":"278","author":"D Portilla","year":"2000","unstructured":"Portilla D, Dai G, Peters JM, Gonzalez FJ, Crew MD, Proia AD. Etomoxir-induced PPAR\u03b1-modulated enzymes protect during acute renal failure. Am J Physiol Renal Physiol. 2000;278(4):F667\u201375.","journal-title":"Am J Physiol Renal Physiol"},{"issue":"10","key":"1253_CR10","doi-asserted-by":"publisher","first-page":"2282","DOI":"10.1194\/jlr.M500217-JLR200","volume":"46","author":"MS Kim","year":"2005","unstructured":"Kim MS, Shigenaga JK, Moser AH, Feingold KR, Grunfeld C. Suppression of estrogen-related receptor \u03b1 and medium-chain acyl-coenzyme A dehydrogenase in the acute-phase response. J Lipid Res. 2005;46(10):2282\u20138. doi: 10.1194\/jlr.M500217-JLR200 .","journal-title":"J Lipid Res"},{"key":"1253_CR11","doi-asserted-by":"publisher","first-page":"F1070","DOI":"10.1152\/ajprenal.00365.2011","volume":"303","author":"Y Muroya","year":"2012","unstructured":"Muroya Y, Ito O, Rong R, Takashima K, Ito D, Cao P, et al. Disorder of fatty acid metabolism in the kidney of PAN-induced nephrotic rats. Am J Physiol Renal Physiol. 2012;303:F1070\u20139. doi: 10.1152\/ajprenal.00365.2011 .","journal-title":"Am J Physiol Renal Physiol"},{"issue":"11","key":"1253_CR12","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1291\/hypres.26.929","volume":"26","author":"T Ishizuka","year":"2003","unstructured":"Ishizuka T, Ito O, Tan L, Ogawa S, Kohzuki M, Omata K, et al. Regulation of cytochrome P-450 4A activity by peroxisome proliferator-activated receptors in the rat kidney. Hypertens Res. 2003;26(11):929\u201336.","journal-title":"Hypertens Res"},{"issue":"2","key":"1253_CR13","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1161\/01.RES.62.2.367","volume":"62","author":"BL Kasiske","year":"1988","unstructured":"Kasiske BL, O\u2019Donnell MP, Garvis WJ, Keane WF. Pharmacologic treatment of hyperlipidemia reduces glomerular injury in rat 5\/6 nephrectomy model of chronic renal failure. Circ Res. 1988;62(2):367\u201374.","journal-title":"Circ Res"},{"issue":"1 Pt 2","key":"1253_CR14","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1161\/01.HYP.31.1.225","volume":"31","author":"TW Wilson","year":"1998","unstructured":"Wilson TW, Alonso-Galicia M, Roman RJ. Effects of lipid-lowering agents in the Dahl salt-sensitive rat. Hypertension. 1998;31(1 Pt 2):225\u201331.","journal-title":"Hypertension"},{"issue":"3","key":"1253_CR15","doi-asserted-by":"publisher","first-page":"F556","DOI":"10.1152\/ajprenal.90613.2008","volume":"296","author":"P Luo","year":"2009","unstructured":"Luo P, Zhou Y, Chang HH, Zhang J, Seki T, Wang CY, et al. Glomerular 20-HETE, EETs, and TGF-beta1 in diabetic nephropathy. Am J Physiol Renal Physiol. 2009;296(3):F556\u201363. doi: 10.1152\/ajprenal.90613.2008 .","journal-title":"Am J Physiol Renal Physiol"},{"issue":"3","key":"1253_CR16","doi-asserted-by":"publisher","first-page":"202","DOI":"10.1038\/hr.2013.143","volume":"37","author":"DA Nugrahaningsih","year":"2014","unstructured":"Nugrahaningsih DA, Emoto N, Vignon-Zellweger N, Purnomo E, Yagi K, Nakayama K, et al. Chronic hyperaldosteronism in cryptochrome-null mice induces high-salt- and blood pressure-independent kidney damage in mice. Hypertens Res. 2014;37(3):202\u20139. doi: 10.1038\/hr.2013.143 .","journal-title":"Hypertens Res"},{"issue":"5","key":"1253_CR17","doi-asserted-by":"publisher","first-page":"1628","DOI":"10.1046\/j.1523-1755.2002.00618.x","volume":"62","author":"A Kamijo","year":"2002","unstructured":"Kamijo A, Kimura K, Sugaya T, Yamanouchi M, Hase H, Kaneko T, et al. Urinary free fatty acids bound to albumin aggravate tubulointerstitial damage. Kidney Int. 2002;62(5):1628\u201337. doi: 10.1046\/j.1523-1755.2002.00618.x .","journal-title":"Kidney Int"},{"issue":"10","key":"1253_CR18","doi-asserted-by":"publisher","first-page":"2696","DOI":"10.1093\/ndt\/gfl448","volume":"21","author":"H Boulanger","year":"2006","unstructured":"Boulanger H, Mansouri R, Gautier JF, Glotz D. Are peroxisome proliferator-activated receptors new therapeutic targets in diabetic and non-diabetic nephropathies? Nephrol Dial Transplant. 2006;21(10):2696\u2013702. doi: 10.1093\/ndt\/gfl448 .","journal-title":"Nephrol Dial Transplant"},{"issue":"3","key":"1253_CR19","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1016\/j.taap.2011.02.012","volume":"252","author":"K Takahashi","year":"2011","unstructured":"Takahashi K, Kamijo Y, Hora K, Hashimoto K, Higuchi M, Nakajima T, et al. Pretreatment by low-dose fibrates protects against acute free fatty acid-induced renal tubule toxicity by counteracting PPARalpha deterioration. Toxicol Appl Pharmacol. 2011;252(3):237\u201349. doi: 10.1016\/j.taap.2011.02.012 .","journal-title":"Toxicol Appl Pharmacol"},{"issue":"5","key":"1253_CR20","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1016\/S0891-5849(01)00632-3","volume":"31","author":"B Qu","year":"2001","unstructured":"Qu B, Li QT, Wong KP, Tan TM, Halliwell B. Mechanism of clofibrate hepatotoxicity: mitochondrial damage and oxidative stress in hepatocytes. Free Radic Biol Med. 2001;31(5):659\u201369.","journal-title":"Free Radic Biol Med"},{"issue":"1","key":"1253_CR21","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1152\/physrev.00021.2001","volume":"82","author":"RJ Roman","year":"2002","unstructured":"Roman RJ. P-450 metabolites of arachidonic acid in the control of cardiovascular function. Physiol Rev. 2002;82(1):131\u201385. doi: 10.1152\/physrev.00021.2001 .","journal-title":"Physiol Rev"},{"key":"1253_CR22","doi-asserted-by":"publisher","DOI":"10.1681\/ASN.2014090868","author":"Y Muroya","year":"2015","unstructured":"Muroya Y, Fan F, Regner KR, Falck JR, Garrett MR, Juncos LA, et al. Deficiency in the Formation of 20-Hydroxyeicosatetraenoic Acid Enhances Renal Ischemia-Reperfusion Injury. J Am Soc Nephrol. 2015;. doi: 10.1681\/ASN.2014090868 .","journal-title":"J Am Soc Nephrol"},{"issue":"5","key":"1253_CR23","doi-asserted-by":"crossref","first-page":"1868","DOI":"10.1128\/MCB.20.5.1868-1876.2000","volume":"20","author":"RB Vega","year":"2000","unstructured":"Vega RB, Huss JM, Kelly DP. The coactivator PGC-1 cooperates with peroxisome proliferator-activated receptor \u03b1 in transcriptional control of nuclear genes encoding mitochondrial fatty acid oxidation enzymes. Mol Cell Biol. 2000;20(5):1868\u201376.","journal-title":"Mol Cell Biol"},{"issue":"1","key":"1253_CR24","doi-asserted-by":"publisher","first-page":"204","DOI":"10.1007\/s00125-012-2747-2","volume":"56","author":"MY Kim","year":"2013","unstructured":"Kim MY, Lim JH, Youn HH, Hong YA, Yang KS, Park HS, et al. Resveratrol prevents renal lipotoxicity and inhibits mesangial cell glucotoxicity in a manner dependent on the AMPK-SIRT1-PGC1alpha axis in db\/db mice. Diabetologia. 2013;56(1):204\u201317. doi: 10.1007\/s00125-012-2747-2 .","journal-title":"Diabetologia"},{"issue":"10","key":"1253_CR25","doi-asserted-by":"publisher","first-page":"1101","DOI":"10.1016\/j.bbagen.2008.06.002","volume":"1780","author":"N Nakai","year":"2008","unstructured":"Nakai N, Kawano F, Terada M, Oke Y, Ohira T, Ohira Y. Effects of peroxisome proliferator-activated receptor alpha (PPARalpha) agonists on leucine-induced phosphorylation of translational targets in C2C12 cells. Biochim Biophys Acta. 2008;1780(10):1101\u20135. doi: 10.1016\/j.bbagen.2008.06.002 .","journal-title":"Biochim Biophys Acta"},{"issue":"7029","key":"1253_CR26","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1038\/nature03354\/nature03354","volume":"434","author":"JT Rodgers","year":"2005","unstructured":"Rodgers JT, Lerin C, Haas W, Gygi SP, Spiegelman BM, Puigserver P. Nutrient control of glucose homeostasis through a complex of PGC-1alpha and SIRT1. Nature. 2005;434(7029):113\u20138. doi: 10.1038\/nature03354\/nature03354 .","journal-title":"Nature"},{"issue":"6","key":"1253_CR27","doi-asserted-by":"publisher","first-page":"429","DOI":"10.1016\/j.cmet.2006.04.013","volume":"3","author":"C Lerin","year":"2006","unstructured":"Lerin C, Rodgers JT, Kalume DE, Kim SH, Pandey A, Puigserver P. GCN5 acetyltransferase complex controls glucose metabolism through transcriptional repression of PGC-1alpha. Cell Metab. 2006;3(6):429\u201338. doi: 10.1016\/j.cmet.2006.04.013 .","journal-title":"Cell Metab"},{"issue":"11","key":"1253_CR28","doi-asserted-by":"publisher","first-page":"1889","DOI":"10.1096\/fj.05-5189fje","volume":"20","author":"S Borniquel","year":"2006","unstructured":"Borniquel S, Valle I, Cadenas S, Lamas S, Monsalve M. Nitric oxide regulates mitochondrial oxidative stress protection via the transcriptional coactivator PGC-1alpha. FASEB J. 2006;20(11):1889\u201391. doi: 10.1096\/fj.05-5189fje .","journal-title":"FASEB J"},{"issue":"1","key":"1253_CR29","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/S0006-2952(00)00308-7","volume":"60","author":"LM Walker","year":"2000","unstructured":"Walker LM, Shah SV, Mayeux PR. Lack of a role for inducible nitric oxide synthase in an experimental model of nephrotic syndrome. Biochem Pharmacol. 2000;60(1):137\u201343.","journal-title":"Biochem Pharmacol"},{"issue":"1\u20132","key":"1253_CR30","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1016\/j.mrfmmm.2005.02.024","volume":"579","author":"M Newaz","year":"2005","unstructured":"Newaz M, Blanton A, Fidelis P, Oyekan A. NAD(P)H oxidase\/nitric oxide interactions in peroxisome proliferator activated receptor (PPAR)alpha-mediated cardiovascular effects. Mutat Res. 2005;579(1\u20132):163\u201371. doi: 10.1016\/j.mrfmmm.2005.02.024 .","journal-title":"Mutat Res"}],"container-title":["Clinical and Experimental Nephrology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10157-016-1253-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10157-016-1253-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10157-016-1253-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10157-016-1253-0","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,9,5]],"date-time":"2019-09-05T04:27:55Z","timestamp":1567657675000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10157-016-1253-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,3,7]]},"references-count":30,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2016,12]]}},"alternative-id":["1253"],"URL":"https:\/\/doi.org\/10.1007\/s10157-016-1253-0","relation":{},"ISSN":["1342-1751","1437-7799"],"issn-type":[{"value":"1342-1751","type":"print"},{"value":"1437-7799","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,3,7]]}}}